Intraperitoneal injections having doses of 1015 mg/kg/day for two weeks in people exhibit features analogous to those observed in animal models [31]
This dual mechanismrapid weight loss combined with potential direct effects on gallbladder functionmay explain the observed association between GLP-1 therapy and gallstone risk
GLP-1 RAs in combination with metformin showed even more weight loss and improvement in markers of hyperandrogenism
BPC-157 & TB-500 Peptides and Angiogenic Action BPC-157 & TB-500 blend may exert angiogenic action
Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice
Cherney DZ, Dekkers CC, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, et al